These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 34453540)

  • 1. Reproductive Health in First-degree Relatives of Patients With Polycystic Ovary Syndrome: A Review and Meta-analysis.
    Shan D; Han J; Cai Y; Zou L; Xu L; Shen Y
    J Clin Endocrinol Metab; 2022 Jan; 107(1):273-295. PubMed ID: 34453540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary Modification for Reproductive Health in Women With Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.
    Shang Y; Zhou H; He R; Lu W
    Front Endocrinol (Lausanne); 2021; 12():735954. PubMed ID: 34790167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased antimüllerian hormone levels and other reproductive endocrine changes in adult male relatives of women with polycystic ovary syndrome.
    Torchen LC; Kumar A; Kalra B; Savjani G; Sisk R; Legro RS; Dunaif A
    Fertil Steril; 2016 Jul; 106(1):50-55. PubMed ID: 27042970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating kisspeptin and anti-müllerian hormone levels, and insulin resistance in women with polycystic ovary syndrome: A systematic review, meta-analysis, and meta-regression.
    Pérez-López FR; Ornat L; López-Baena MT; Santabárbara J; Savirón-Cornudella R; Pérez-Roncero GR
    Eur J Obstet Gynecol Reprod Biol; 2021 May; 260():85-98. PubMed ID: 33744505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polycystic ovary syndrome and anti-Müllerian hormone: role of insulin resistance, androgens, obesity and gonadotrophins.
    Cassar S; Teede HJ; Moran LJ; Joham AE; Harrison CL; Strauss BJ; Stepto NK
    Clin Endocrinol (Oxf); 2014 Dec; 81(6):899-906. PubMed ID: 25040369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polycystic ovaries are inherited as an autosomal dominant trait: analysis of 29 polycystic ovary syndrome and 10 control families.
    Govind A; Obhrai MS; Clayton RN
    J Clin Endocrinol Metab; 1999 Jan; 84(1):38-43. PubMed ID: 9920059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
    Yildiz BO; Yarali H; Oguz H; Bayraktar M
    J Clin Endocrinol Metab; 2003 May; 88(5):2031-6. PubMed ID: 12727950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opposing effects of dehydroepiandrosterone sulfate and free testosterone on metabolic phenotype in women with polycystic ovary syndrome.
    Lerchbaum E; Schwetz V; Giuliani A; Pieber TR; Obermayer-Pietsch B
    Fertil Steril; 2012 Nov; 98(5):1318-25.e1. PubMed ID: 22835450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CORRELATION BETWEEN LEVELS OF HOMOCYSTEINE, ANTI-MÜLLERIAN HORMONE AND INSULIN RESISTANCE IN PCOS PATIENTS WITH RECURRENT MISCARRIAGE.
    Asanidze E; Kristesashvili J; Andguladze S
    Georgian Med News; 2019 May; (290):25-29. PubMed ID: 31322509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
    Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E
    Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Tea Consumption on Anthropometric Parameters, Metabolic Indexes and Hormone Levels of Women with Polycystic Ovarian Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Shen W; Pan Y; Jin B; Zhang Z; You T; Qu Y; Han M; Yuan X; Zhang Y
    Front Endocrinol (Lausanne); 2021; 12():736867. PubMed ID: 34966355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-Müllerian hormone as an indicator of reproductive health in women with obesity and concomitant polycystic ovary syndrome].
    Durmanova AK; Otarbaev NK
    Ter Arkh; 2016; 88(12):41-44. PubMed ID: 28139558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of women with elevated antimüllerian hormone levels (AMH): correlation of AMH with polycystic ovarian syndrome phenotypes and assisted reproductive technology outcomes.
    Tal R; Seifer DB; Khanimov M; Malter HE; Grazi RV; Leader B
    Am J Obstet Gynecol; 2014 Jul; 211(1):59.e1-8. PubMed ID: 24593938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Müllerian hormone gene polymorphism is associated with androgen levels in Chinese polycystic ovary syndrome patients with insulin resistance.
    Zheng MX; Li Y; Hu R; Wang FM; Zhang XM; Guan B
    J Assist Reprod Genet; 2016 Feb; 33(2):199-205. PubMed ID: 26732661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-Mullerian hormone in the major phenotypes of polycystic ovary syndrome].
    Parahuleva N; Pehlivanov B; Orbecova M; Uchikova E; Ivancheva H
    Akush Ginekol (Sofiia); 2014; 53(5):22-7. PubMed ID: 25558667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AMH in combination with SHBG for the diagnosis of polycystic ovary syndrome.
    Calzada M; López N; Noguera JA; Mendiola J; Hernández AI; Corbalán S; Sanchez M; Torres AM
    J Obstet Gynaecol; 2019 Nov; 39(8):1130-1136. PubMed ID: 31208261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
    Lie Fong S; Laven JSE; Duhamel A; Dewailly D
    Hum Reprod; 2017 Aug; 32(8):1723-1731. PubMed ID: 28854584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asprosin levels in women with and without the polycystic ovary syndrome: a systematic review and meta-analysis.
    Pérez-López FR; López-Baena MT; Pérez-Roncero GR; Chedraui P; Varikasuvu SR; García-Alfaro P
    Gynecol Endocrinol; 2023 Dec; 39(1):2152790. PubMed ID: 36480935
    [No Abstract]   [Full Text] [Related]  

  • 19. Pregnancy and neonatal complications in women with polycystic ovary syndrome in relation to second-trimester anti-Müllerian hormone levels.
    Valdimarsdottir R; Valgeirsdottir H; Wikström AK; Kallak TK; Elenis E; Axelsson O; Ubhayasekhera K; Bergquist J; Piltonen TT; Pigny P; Giacobini P; Poromaa IS
    Reprod Biomed Online; 2019 Jul; 39(1):141-148. PubMed ID: 31036431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity of Endocrinologic and Metabolic Parameters in Reproductive Age Polycystic Ovary Syndrome (PCOS) Women Concerning the Severity of Hyperandrogenemia-A New Insight on Syndrome Pathogenesis.
    Ozegowska K; Korman M; Szmyt A; Pawelczyk L
    Int J Environ Res Public Health; 2020 Dec; 17(24):. PubMed ID: 33322590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.